Syros(SYRS) - 2021 Q3 - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2021 Earnings Conference Call November 5, 2021 8:30 AM ET Company Participants Courtney Solberg - Manager, Corporate Communications Nancy Simonian - President and Chief Executive Officer Jason Haas - Chief Financial Officer David Roth - Chief Medical Officer Kristin Stephens - Chief Development Office Eric Olson - Chief Scientific Officer Conference Call Participants Ted Tenthoff - Piper Jaffray Phil Nadeau - Cowen and Company Jason Butler - JMP Securities Mark B ...